Latest news
Is Opus Genetics Inc (IRD) Significantly Overvalued After Q2 Ear - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:48:49 GMTOPUS GENETICS - MAY OFFER AND SELL UP TO $300 MLN OF SECURITIES - SEC FILING - MoomooMoomoo · Sat, 08 Aug 2026 06:41:34 GMTOpus Genetics (NASDAQ:IRD) Upgraded at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:03 GMTOpus Genetics (IRD) Stock Stalls As Revenue Shrinks And Losses Deepen - simplywall.stsimplywall.st · Fri, 07 Aug 2026 23:48:13 GMTRBC Adjusts PT on Opus Genetics to $9 From $10, Maintains Outperform Speculative Risk Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 12:52:58 GMTOpus Genetics (NASDAQ: IRD) sets $300M shelf and $125M ATM stock plan - Stock TitanStock Titan · Fri, 07 Aug 2026 10:57:57 GMTOpus Genetics (Nasdaq: IRD) hit by $73.6M loss, rising warrant costs - Stock TitanStock Titan · Thu, 06 Aug 2026 20:32:59 GMTOpus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:20:07 GMT